The ELRIG Cell and Gene Therapy 2026 is a free-to-attend, two-day scientific conference scheduled for March 9–10, 2026, in Cambridge, UK.

Organized by the European Laboratory Research and Innovation Group (ELRIG), this event focuses on the translational journey of advanced therapies from preclinical innovation to clinical application. The technical program features four key tracks: gene therapies for neurological disorders, advancements in sensory disorder treatments, scaling solutions for rare diseases, and next-generation cancer immunotherapy.

The oncology-specific track, titled “Engineering the Future of Cancer Immunotherapy: Advances in T Cell Design and Function,” explores cutting-edge developments in CAR and TCR engineering, strategies to improve the safety and durability of T-cell therapies, and technologies aimed at making these treatments more accessible for both hematological and solid malignancies.

Register.